Advances in Diabetes and Thyroid Disease 2012

Advances in Diabetes and Thyroid Disease 2012

SPACE IS LIMITED. REGISTER TODAY AT:

November 1 –3, 2012The Fairmont Copley Plaza HotelBoston, Massachusetts

Martin J. Abrahamson, MD Associate Professor of Medicine Harvard Medical School Medical Director Joslin Diabetes Center

Richard S. Beaser, MD Associate Clinical Professor of Medicine Harvard Medical School Medical Executive Director, Professional Education Joslin Diabetes Center

James V. Hennessey, MD Director, Clinical Endocrinology Division of Endocrinology Beth Israel Deaconess Medical Center

Course Directors

A comprehensive Harvard Medical School CME activity addressing practical aspects of diabetes and thyroid disease care and management, including the use of new technologies that address the growing

complexity of diabetes care and the challenges of managing chronic illness in a primary care practice

WWW.CME.HMS.HARVARD.EDU/COURSES/JOSLIN

Register by June 21 and save $200!

2 Advances in Diabetes and Thyroid Disease 2012

Why You Should AttendBecause the majority of people with diabetes and thyroid disease are cared for by their primary care providers, PCPs need a comprehensive review and update on clinical management to provide optimal care. This annual CME course, initiated more than century ago by Elliott P. Joslin, MD, in conjunction with Harvard Medical School, is the longest-running academic course in diabetes in the United States and, likely, the world. The course has evolved with diabetes practice and research as well as the changing continuing education needs of the medical profession, incorporating participant interaction in smaller breakout sessions, interactive workshops, and question-and-answer opportunities for a dynamic learning experience.

Topics• Thyroid and parathyroid diseases

• Obesity

• What the PCP needs to know about • Lifestyle approaches• Noninsulin medications• Insulin

• Diabetes complications

• Prevention of type 2 diabetes

• Special populations

• And more!

Learning ObjectivesUpon completion of this activity, participants will be able to:

• Describe recent advances in the understanding of the patho-physiology of type 1 and type 2 diabetes, as well as comor-bidities of these conditions

• Describe advances in research related to the treatment of diabetes and related conditions that have translated into improved glucose control, complication prevention/treatment, and quality of life for people living with this condition

• Demonstrate skills in advancing therapies for glycemic control aimed at achieving recommended treatment targets

• Identify specific changes that they will make in their practices regarding care of people with diabetes and comorbidities based on updated knowledge of state-of-the-art treatment approaches

• List improvements in skills in caring for people with diabetes and related conditions based on participation in presentations and discussions of clinical case scenarios

• Describe the incidence, clinical impact, and morbidity of hyperthyroidism, hypothyroidism, thyroid dysfunction during pregnancy, and thyroid nodules

• Discuss methods to diagnose hyperthyroidism, hypothyroid-ism, thyroid dysfunction affecting pregnancy, and thyroid nodules when they are encountered in primary care practice

• Summarize approaches to treatment and/or collaborative interventions for hyperthyroidism, hypothyroidism, and thyroid nodules.

ACGME CompetenciesThis course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies:

• Patient care

• Medical knowledge

• Practice-based learning and improvement

This year, to mark the 90th anniversary of the first use of insulin, the course will highlight both the history of and the latest developments in insulin treatment.

Advances in Diabetes and Thyroid Disease 2012

3

Day 1: November 1, 2012

7:00 Registration and Continental Breakfast

7:45 Welcome and Introduction Abrahamson

8:00 Prevention of Cardiovascular Disease Stanton

9:00 Hypothyroidism Garber

9:45 Hyperthyroidism Hartzband

10:30 Break

10:45 Thyroid Nodules Hennessy

11:30 Primary Care Role in the Identifica-tion of Thyroid Disease in Pregnancy

Hollenberg

12:15 Panel Discussion and Q&A Session

12:45 Lunch (on your own)

1:45 Keynote Lecture: Can We Prevent T2DM?

Horton

2:30 Pediatric Lecture Laffel

3:15 Elderly Lecture Munshi

4:00 Break

4:15 Rejuvenation Exercises

4:30 Motivational Interviewing Domino

5:15 Break (on your own)

5:30 Stones, Groans, and Bones: Hyperparathyroidism, Vitamin D, and a Primary Care Approach to Osteoporosis Therapies

5:30 Dinner

6:00 Welcome and Introduction Hennessey

6:15 Primary Hyperparathyroidism: Key Considerations for the Primary Care Physician

Pallotta

6:45 Vitamin D and Bone Health: What Do the Current, Conflicting Recommendations Mean for the Primary Care Physician?

Malabanan

7:15 Osteoporosis 2012: DXA Detection, Monitoring Intervals, and the Use of the Newest Medications for the Primary Care Physician

Rosen

7:45 Q&A Session All Faculty

8:00 Adjourn Abrahamson & Beaser

Day 2: November 2, 2012

7:30 Continental Breakfast

8:00 Keynote Lecture: Brown Fat: What You Need to Know

Cypess

8:45 Lifestyle Modifications Phillips & Arathuzik

9:45 Break

10:00 Noninsulin Treatment of Diabetes: What the PCP Needs to Know

Abrahamson

10:45 Insulin Treatment of Diabetes: What the PCP Needs to Know

Beaser

11:30 Q&A Session Abrahamson & Beaser

11:45 Lunch (on your own) and Fitness Walk

12:45 Simultaneous Workshops

Problem-Solving and Clinical Pearls Abrahamson

Insulin and Noninsulin Medications Beaser

1:30 Cultural Considerations: Asian Patients

Hsu

2:15 Diabetes in the Latino Population Caballero

3:00 Break

3:15 Recent Advances in the Treatment of Complications: Neuropathy

Gibbons

4:00 Eye Disease Aiello

4:30 Rejuvenation Exercises

4:45 Peripheral Vascular Disease Campbell

5:15 OSA Pogach

5:45 Break (on your own)

6:15 Special Highlight: 90th Anniversary of the Use of Insulin

6:15 Dinner

6:45 Introduction and Historical Perspective

Abrahamson & Beaser

7:15 Reflections of a Diabetologist Younger

7:45 New Insulins TBD

8:15 CGM and New Insulin Products and Devices

Wolpert

8:45 Q&A Session All Faculty

9:00 Adjourn Abrahamson & Beaser

(continued)

Agenda*

4 Advances in Diabetes and Thyroid Disease 2012

Day 3: November 3, 2012

7:30 Continental Breakfast

8:00 Keynote Lecture: Insights into Liver Disease

Chopra

8:45 Inpatient Treatment of Diabetes Hamdy

9:30 Lipids Ganda

10:15 Break

10:30 Diabetic Foot Treatment Giurini

11:15 Cardiovascular Disease Cutlip

12:00 Lunch (on your own)

1:00 Simultaneous Workshops

Problem-Solving and Clinical Pearls Abrahamson

Insulin and Noninsulin Medications Beaser

1:45 Obesity Intensive Session: Nonsurgical Hamdy

2:25 Obesity Intensive Session: Surgical Jones

3:05 Patient Experiences (Both Scenarios)

3:45 Adjourn

Martin J. Abrahamson, MDAssociate Professor of Medicine Harvard Medical School Medical Director and Senior Vice President Joslin Diabetes Center

Lloyd P. Aiello, MD, PhDAssociate Professor of Ophthalmology Harvard Medical School Director, Beetham Eye Institute Head, Section on Eye Research Joslin Diabetes Center

Gillian Arathuzik, RD, LDN, CDENutrition Diabetes Educator Joslin Diabetes Center

Richard S. Beaser, MDAssociate Clinical Professor of Medicine Harvard Medical School Medical Executive Director Professional Education Joslin Diabetes Center

Enrique Caballero, MDAssistant Professor of Medicine Harvard Medical School Director, Medical Affairs Professional Education Director, Latino Diabetes Initiative Joslin Diabetes Center

David R. Campbell, MDAssociate Clinical Professor of Surgery Harvard Medical School Vascular Surgeon Beth Israel Deaconess Medical Center

Sanjiv Chopra, MBBS, MACP Professor of Medicine Faculty Dean for Continuing Education Harvard Medical School Senior Consultant in Hepatology Beth Israel Deaconess Medical Center

Donald E. Cutlip, MDAssociate Professor of Medicine Harvard Medical School Director, Cardiac Catheterization Laboratory Beth Israel Deaconess Medical Center Executive Director Clinical Trials Harvard Clinical Research Institute

Agenda* (continued) Faculty*

*Program changes/substitutions may be made without notice

This activity has been submitted for independent commercial grant support. No support had been awarded when this brochure went to press.

Accreditation and Designation of CreditThe Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 28.5 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Space is limited. Register by June 21 and save $200. Register by September 21 and save $100.

Copyright ©2012 by Joslin Diabetes center. All rights reserved.

5

Aaron M. Cypess, MD, PhD, MMScAssistant Professor Harvard Medical School Assistant Investigator and Staff Physician Joslin Diabetes Center

Frank Domino, MDClerkship Director in Family MedicineChair of the Clinical Years Curriculum CommitteeUniversity of Massachusetts Medical School

Jason L. Gaglia, MDInstructor in MedicineHarvard Medical SchoolStaff PhysicianJoslin Diabetes Center

Om P. Ganda, MDAssociate Clinical Professor of Medicine Harvard Medical School Director, Lipid Clinic Joslin Diabetes Center

Jeffrey R. Garber, MD, FACP, FACEAssociate Professor Harvard Medical School Chief of Endocrinology Harvard Vanguard Medical Associates Immediate Past President, American Association of Clinical Endocrinologists

Christopher Gibbons, MD, MMScInstructor in Neurology Harvard Medical School Beth Israel Deaconess Medical Center Joslin Diabetes Center

John M. Giurini, DPMAssociate Professor in Surgery Harvard Medical School Chief, Division of PodiatryBeth Israel Deaconess Medical Center

Osama Hamdy, MD, PhD, FACEHarvard Medical School Medical Director Obesity Clinical Program Joslin Diabetes Center

Pamela Hartzband, MDAssistant Professor of Medicine Harvard Medical School Medical Director, Thyroid Nodule Clinic Division of Endocrinology Beth Israel Deaconess Medical Center

James V. Hennessey, MDDirector, Clinical Endocrinology Division of Endocrinology Beth Israel Deaconess Medical Center

Anthony Hollenberg, MDAssociate Professor of Medicine Harvard Medical School Chief, Thyroid Unit Beth Israel Deaconess Medical Center

Edward S. Horton, MDProfessor of Medicine Harvard Medical School Senior Investigator Joslin Diabetes Center

William C. Hsu, MDAssistant Professor of Medicine Harvard Medical School Director, Asian Clinic Joslin Diabetes Center

Daniel B. Jones, MD, FACSAssociate Professor Harvard Medical School Chief, Section of Minimally Invasive Surgery Beth Israel Deaconess Medical Center

Lori Laffel, MD, MPHAssociate Professor of Pediatrics Harvard Medical School Chief, Pediatric, Adolescent and Young Adult Section Investigator, Genetics and Epidemiology Section Joslin Diabetes Center

Alan O. Malabanan, MD, FACEAssistant Professor of Medicine Harvard Medical School Associate Training Program Director, Endocrinology Beth Israel Deaconess Medical Center

Medha Munshi, MDAssistant Professor of Medicine Harvard Medical School Director of Joslin Geriatric Diabetes Programs Beth Israel Deaconess Medical Center

Johanna A. Pallotta, MD, FACP, FACEAssociate Professor of Medicine Harvard Medical School Senior Physician Beth Israel Deaconess Medical Center

Edward M. Phillips, MDAssistant Professor of Physical Medicine and Rehabilitation Harvard Medical School Director, Outpatient Medical Services Spaulding Rehabilitation Hospital Network Assistant Physiatrist Massachusetts General Hospital Adjunct Scientist Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University

Melanie Pogach, MDInstructor in Medicine Harvard Medical School Division of Pulmonary, Critical Care and Sleep Medicine Beth Israel Deaconess Medical Center

Harold Rosen, MDAssistant Professor of Medicine Harvard Medical School Director, Osteoporosis Prevention and Treatment Center Beth Israel Deaconess Medical Center

Robert C. Stanton, MDAssociate Professor of Medicine Harvard Medical School Chief of Nephrology Joslin Diabetes Center

Howard A. Wolpert, MDAssistant Professor of Medicine Harvard Medical School Director, Insulin Pump Program Senior Physician Joslin Diabetes Center

Donna Younger, MD, FACPAssistant Medical ProfessorHarvard Medical SchoolStaff PhysicianJoslin Diabetes CeneterStaff PhysicianBeth Israel Deaconess Medical Center

*Subject to change

REGISTER TODAY!

WWW.CME.HMS.HARVARD.EDU/COURSES/JOSLIN

6 Advances in Diabetes and Thyroid Disease 2012

Performance Improvement CME is a construct introduced by the AMA in 2004. Completion of PI CME stages can result in up to 20 AMA PRA Category 1 Credits.™ All four of the above pathways are approved through the American Board of Internal Medicine’s (ABIM) Approved Quality Improvement (AQI) Pathway and are eligible for 20 points towards the Self-Evaluation of Practice Performance require-ment of Maintenance of Certification (MOC). For more information, go to www.abim.org/moc/.

Visit www.jpec.joslin.org to get started.

What your colleagues are saying about Advances in Diabetes and Thyroid Disease

Registration Information

“This was one of the best conferences I have attended in my entire career. It was a realistic

view of the diabetic patient as well as the thyroid patient. The speakers were very knowledgeable and

able to articulate their knowledge well.”

“It gave me some food for thought about a few difficult patients that I have not known how to

follow. Thank you.”

“Very helpful. I look forward to using the online resources as well.”

“I love the practical approach and pearls.”

“Providers are up to date and part of ongoing research on the topic. The case-based workshops on oral meds and insulin were especially helpful.”

InquiriesBy phone 617-384-8600, Monday–Friday, 10 AM to 4 PM (EDT) or by e-mail at [email protected].

Online InformationTo register or view activity information online, visit www.cme.hms.harvard.edu/courses/joslin.

Disclosure PolicyHarvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g., planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Refund PolicyA handling fee of $60 is deducted for cancellation. Refund requests must be received by postal mail, e-mail, or fax one week prior to this activity. No refunds will be made thereafter.

Course LocationAll sessions for this course will be held at the Fairmont Copley Plaza Hotel, 138 St. James Avenue, Boston, MA(Telephone: 1-800-441-1414 or 617-267-5300).

Accommodations/TravelA limited number of rooms have been reserved at the Fairmont Copley Plaza Hotel (Telephone: 1-800-441-1414) until October 11, 2012. Please specify that you are enrolled in this course to receive a reduced room rate of $299 per night for Moderate and Fairmont Rooms (limited quantity) and $329 per night for Deluxe Rooms. Hotel arrangements can also be made online at https:/resweb.passkey.com/go/joslindiabetes. Please do not purchase nonrefundable airline ticket(s) until you have received an e-mail from our office confirming your paid registration. For airline reservations contact the HMS Travel Desk toll-free 1-877-4-HARVMD (1-877-442-7863) Monday–Friday 9 AM–8 PM (EDT). From outside the U.S., Canada, and Virgin Islands, please call 617-559-3764.

In compliance with the Americans with Disabilities Act, Harvard Medical School will make every reasonable effort to accommodate your needs during your attendance at this activity. For any special requests, please contact Joslin Diabetes Center at 888-567-5460.

Affiliated Performance Improvement CME (PI CME) through the Joslin Professional Education Continuum (JPEC)

This activity is aligned with four PI CME Pathways available via JPEC at www.jpec.joslin.org.

1. Type 2 Diabetes Office Systems2. Insulin Therapy3. Advancing Therapies for Type 2 Diabetes4. Cardiometabolic Risk

7

One registrant per form, please—you may photocopy the form for others. Print clearly—all fields required.Please check the type of registration:

Physician Resident, Fellow in Training, Allied Health Professional Nonclinical Industry Professional $__________________

Full Name ____________________________________________________________________________________________________

Address ______________________________________________________________________________________________________

City ______________________________________________________State ________ Zip Code _______________________________

Country ______________________________________________________________________________________________________

Daytime Phone ______________________________________________ Fax Number _______________________________________

Please note: Your e-mail address is used for critical information about the course including registration confirmation, evaluation, and certificate. Please be sure to include an e-mail address you check daily or frequently.

E-Mail Address ________________________________________________________________________________________________

Please check if you wish to be excluded from e-mail notices of future Harvard Medical School – Department of Continuing Education programs.

Profession _______________________________________________________ Degree ______________________________________

Primary Specialty (Physicians only) _______________________________________________________ Board Certified: Yes No

Professional School Attended (Physicians only)

Harvard Medical School U.S. Medical School International Year of Graduation _________________________________

Attendance is limited—register early and save up to $200! Registration by credit card (VISA or MasterCard) can be made at www.cme.hms.harvard.edu/courses/joslin. Registration by check (draft on a United States bank), please make payable to Harvard Medical School and mail with this page to Harvard Medical School–Department of Continuing Education, PO Box 417476, Boston, MA 02241-7476. Telephone or fax registration is not accepted. Registration with cash payment is not permitted. Upon receipt of your paid registration an e-mail confirmation from the HMS-DCE office will be sent to you. Be sure to include an e-mail address that you check frequently. Your e-mail address is used for critical information including registration confirmation, evaluation, and certificate.

Registration Form

Registration Information

Tuition Fee Through June 21 June 22–September 21 After September 21Physicians $495 (USD) $595 (USD) $695 (USD)

Residents, Fellows in Training, Allied Health Professionals $395 (USD) $495 (USD) $595 (USD)

Nonclinical Industry Professional $795 (USD) $895 (USD) $995 (USD)

Advances in Diabetes and Thyroid Disease 2012 November 1–3, 2012